Mayersohn Joel David 4
4 · CITIUS ONCOLOGY, INC. · Filed Dec 16, 2024
Insider Transaction Report
Form 4
Mayersohn Joel David
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-12-12+250,000→ 250,000 totalExercise: $1.07Exp: 2034-12-12→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The options were granted on December 12, 2024. The options will vest 100% on the one-year anniversary of the grant date, provided that the Optionee provides Continuous Service to the Company as of the vesting date